<DOC>
	<DOCNO>NCT02900495</DOCNO>
	<brief_summary>Children refer pediatric urology clinic primary nocturnal enuresis screen enrollment . Patients fail behavioral therapy meet inclusion criterion offer therapy TENS unit . Patients randomize four group . Group 1 direct bladder stimulation arm electrode place onto abdomen suprapubic region directly bladder . Group 2 distal neural loop arm electrode place posterior tibial nerve . Group 3 proximal neural loop arm electrode place 2-3 cm lateral midline sacral region level S3 . Group 4 control arm electrode place scapula . We aim recruit 32 patient per group total 128 patient . The patient provide TENS unit ( TENS 3000 Analog ) electrode pad caretaker instruct use apparatus . The TENS session perform nightly bed 20 minute . TENS unit set frequency 10 Hz , intensity determine sensitivity threshold patient . Diaries include nighttime incontinence episodes `` wet sheet '' scale ( dry , damp , wet , soak ) record , along adverse reaction TENS unit . Patients follow one month TENS evaluation include Pediatric Urinary Incontinence Questionnaire , validate tool measuring quality life child bladder dysfunction ; questionnaire fill prior start TENS treatment order compare effect treatment QOL . . They follow parameter another month ( one month TENS therapy ) ass durability treatment effect . The data collect different time point ( baseline , 1 month , 2 month ) group group compare use statistical analysis .</brief_summary>
	<brief_title>Transcutaneous Electric Nerve Stimulation ( TENS ) Treatment Nocturnal Enuresis Children</brief_title>
	<detailed_description>Institutional review board obtain . Children age 5-18 year old refer pediatric urology clinic primary nocturnal enuresis screen enrollment . Behavioral therapy ( limit even drinking , double void prior bedtime , bowel habit , social anxiety factor ) utilize first . Patients fail next offer therapy bedwetting alarm device TENS unit alternative , choose TENS therapy include study . Patients previously try pharmacologic treatment nocturnal enuresis , neuromodulation alternative therapy urologic disorder , daytime incontinence symptom , know `` high volume '' voider ( determined history ) , bedwetting episodes average less two time per week , medication predispose incontinence ( eg , Lithium bipolar disorder ) , know void neurologic disorder ( eg , overactive bladder , myelomeningocele ) , secondary etiology nocturnal enuresis ( eg , cystitis , obstructive sleep apnea , urinary fistula ) , contraindication usage TENS unit pacemaker exclude . Patients previously try bedwetting alarm exclude study . 128 patient choose enrollment study . The patient randomize four group 32 patient . Group 1 direct bladder stimulation arm electrode place onto abdomen suprapubic region directly bladder . Group 2 distal neural loop arm electrode place onto bottom foot . Group 3 proximal neural loop arm electrode place 2-3 cm lateral midline sacral region level S3 . Group 4 sham arm electrode place scapula . We aim recruit 30 patient per group total 120 patient . Detailed explanation purpose study , along risk benefit TENS give patient caretaker provider prior obtaining inform consent enrollment study . The patient provide TENS unit electrode pad caretaker instruct use apparatus . Parents enrol patient fill nightly void diary , record nighttime incontinence episode subjective `` wet sheet '' scale per night ( dry , damp , wet , soak ) 30 day prior randomization treatment arm . The TENS session perform nightly bedtime 20 minute 30 day . TENS unit set frequency 10 Hz , intensity determine office sensitivity threshold patient . Voiding diary keep night TENS therapy , additionally record TENS setting use , duration therapy night , adverse reaction TENS unit increase symptom ( patient terminate study include treatment failure ) . Diaries keep 30 day TENS therapy complete assess durability treatment effect . At void diary day 30 ( first TENS treatment ) , day 60 ( completion TENS therapy ) , day 90 ( one month TENS ) , patient family fill Pediatric Urinary Incontinence Questionnaire ( PIN-Q ) , validate tool measuring quality life child bladder dysfunction . Patients follow day 0 , 30 , 60 , 90 , need ( worsen symptom , adverse reaction , concern , question regard usage TENS ) . Parents call weekly basis throughout study ensure compliance address question concern . The result mean nightly incontinence episode , mean `` wet sheet '' scale score ( 0-3 ) , PIN-Q measure time point ( baseline , 1 month , 2 month group group compare use statistical analysis .</detailed_description>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Nocturnal Enuresis</mesh_term>
	<criteria>primary nocturnal enuresis wet night occur per week average ability provide inform consent complete study requirement use medication nocturnal enuresis ( DDAVP , imipramine , anticholinergic ) less 30 day time appointment daytime incontinence medication predispose incontinence ( eg , Lithium bipolar disorder ) know void neurologic disorder ( eg , overactive bladder , spina bifida , interstitial cystitis ) secondary etiology nocturnal enuresis ( cystitis , obstructive sleep apnea , urinary fistula ) contraindication TENS unit usage ( pacemaker implantable device , lymphedema , pregnancy , malignancy )</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Nocturnal Enuresis</keyword>
	<keyword>Bedwetting</keyword>
	<keyword>TENS</keyword>
</DOC>